Literature DB >> 16552500

Exploring a mathematical model for the kinetics of beta-amyloid molecular imaging probes through a critical analysis of plaque pathology.

Kooresh Shoghi-Jadid1, Jorge R Barrio, Vladimir Kepe, Sung-Cheng Huang.   

Abstract

Amyloid plaques are highly heterogeneous in content, size, density, and macromolecular crowding, as they are composed of masses of fibrils and other cellular material. Given this target architecture, the aggregated microenvironment offers a unique imaging target for ligands and positron emission tomography (PET) molecular imaging probes (MIPs). In this work, we address how the heterogeneous microenvironment of a plaque and its evolution may affect the kinetic rate constant of PET MIPs. We argue that macromolecular crowding will result in anomalous diffusion within plaque regions. To account for anomalous diffusion within plaques, we propose a diffusion-limited ligand-receptor compartmental model. Given the current state of knowledge about the pathological progression of Alzheimer's disease (AD), the model's parameters may be a function of the pathological progression of AD, which could result in biased estimates of the true amyloid load. The bias may be partially overcome through evaluation in conjunction with other measures of AD progression including cerebral glucose metabolism rate, neuronal cell loss, and activated inflammatory presence.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16552500     DOI: 10.1007/s11307-006-0037-4

Source DB:  PubMed          Journal:  Mol Imaging Biol        ISSN: 1536-1632            Impact factor:   3.488


  48 in total

1.  Monte carlo simulations of enzyme reactions in two dimensions: fractal kinetics and spatial segregation.

Authors:  Hugues Berry
Journal:  Biophys J       Date:  2002-10       Impact factor: 4.033

2.  Demonstration of amyloid deposits and neurofibrillary changes in whole brain sections.

Authors:  H Braak; E Braak
Journal:  Brain Pathol       Date:  1991-04       Impact factor: 6.508

3.  Structural and chemical changes of the aged human brain.

Authors:  R D Terry; H M Wísniewski
Journal:  Psychopharmacol Bull       Date:  1975-10

4.  Analysis of three- and four-compartment models for in vivo radioligand-neuroreceptor interaction.

Authors:  B R Zeeberg; H N Wagner
Journal:  Bull Math Biol       Date:  1987       Impact factor: 1.758

5.  Amyloid-beta peptide-receptor for advanced glycation endproduct interaction elicits neuronal expression of macrophage-colony stimulating factor: a proinflammatory pathway in Alzheimer disease.

Authors:  S Du Yan; H Zhu; J Fu; S F Yan; A Roher; W W Tourtellotte; T Rajavashisth; X Chen; G C Godman; D Stern; A M Schmidt
Journal:  Proc Natl Acad Sci U S A       Date:  1997-05-13       Impact factor: 11.205

6.  Anomalous diffusion due to obstacles: a Monte Carlo study.

Authors:  M J Saxton
Journal:  Biophys J       Date:  1994-02       Impact factor: 4.033

7.  Fractal analysis of senile plaque observed in various animal species.

Authors:  H Nakayama; W Kiatipattanasakul; S Nakamura; K Miyawaki; F Kikuta; K Uchida; K Kuroki; T Makifuchi; Y Yoshikawa; K Doi
Journal:  Neurosci Lett       Date:  2001-01-19       Impact factor: 3.046

8.  Relationship of microglia and astrocytes to amyloid deposits of Alzheimer disease.

Authors:  S Itagaki; P L McGeer; H Akiyama; S Zhu; D Selkoe
Journal:  J Neuroimmunol       Date:  1989-10       Impact factor: 3.478

9.  Ultrastructure of diffuse plaques in senile dementia of the Alzheimer type: comparison with primitive plaques.

Authors:  H Yamaguchi; Y Nakazato; M Shoji; M Takatama; S Hirai
Journal:  Acta Neuropathol       Date:  1991       Impact factor: 17.088

Review 10.  [18F]-fluorodeoxyglucose (FDG) and positron emission tomography (PET) in aging and dementia. A decade of studies.

Authors:  J M Hoffman; B H Guze; L R Baxter; J C Mazziotta; M E Phelps
Journal:  Eur Neurol       Date:  1989       Impact factor: 1.710

View more
  6 in total

Review 1.  A review of imaging agent development.

Authors:  Eric D Agdeppa; Mary E Spilker
Journal:  AAPS J       Date:  2009-05-05       Impact factor: 4.009

2.  The Value of In Vitro Binding as Predictor of In Vivo Results: A Case for [18F]FDDNP PET.

Authors:  Graham B Cole; Nagichettiar Satyamurthy; Jie Liu; Koon-Pong Wong; Gary W Small; Sung-Cheng Huang; Janez Košmrlj; Jorge R Barrio; Andrej Petrič
Journal:  Mol Imaging Biol       Date:  2019-02       Impact factor: 3.488

Review 3.  Pre-clinical detection of Alzheimer's disease using FDG-PET, with or without amyloid imaging.

Authors:  Lisa Mosconi; Valentina Berti; Lidia Glodzik; Alberto Pupi; Susan De Santi; Mony J de Leon
Journal:  J Alzheimers Dis       Date:  2010       Impact factor: 4.472

Review 4.  FDG- and amyloid-PET in Alzheimer's disease: is the whole greater than the sum of the parts?

Authors:  L Mosconi; P F McHugh
Journal:  Q J Nucl Med Mol Imaging       Date:  2011-06       Impact factor: 2.346

Review 5.  The application of positron-emitting molecular imaging tracers in Alzheimer's disease.

Authors:  Robert M Cohen
Journal:  Mol Imaging Biol       Date:  2007 Jul-Aug       Impact factor: 3.488

6.  Evaluation of tracer kinetic models for analysis of [18F]FDDNP studies.

Authors:  Maqsood Yaqub; Ronald Boellaard; Bart N M van Berckel; Nelleke Tolboom; Gert Luurtsema; Anke A Dijkstra; Mark Lubberink; Albert D Windhorst; Philip Scheltens; Adriaan A Lammertsma
Journal:  Mol Imaging Biol       Date:  2009-04-02       Impact factor: 3.488

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.